Guide — Hematology
Thrombocytopenia Nursing Care
Low platelets means bleeding risk — but the cause decides the treatment. The high-yield trap: in TTP and HIT, giving platelets makes things worse, while in ITP and DIC the approach is different again.
8 min read · Hematology
Educational use only. Platelet transfusion thresholds and disorder-specific treatment are provider-directed and individualized. This is educational background for nursing care. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.
Overview
Thrombocytopenia is a platelet count below 150,000/µL. Bleeding risk rises as the count falls, and the count alone drives much of the nursing care. But platelets can be low because they are destroyed (ITP), consumed (TTP, HIT, DIC), or underproduced (marrow failure, chemo) — and the mechanism determines treatment. Two of these disorders are paradoxically clotting diseases (TTP and HIT), where transfusing platelets is harmful.
Key Concepts
ITP — immune thrombocytopenia
Autoantibodies tag platelets for destruction in the spleen. Often follows a viral illness (children) or is chronic (adults). Treated with corticosteroids, IVIG, and sometimes splenectomy. Platelet transfusion is reserved for serious bleeding (transfused platelets are also destroyed).
TTP — thrombotic thrombocytopenic purpura
A deficiency of the enzyme ADAMTS13 lets giant von Willebrand multimers form microthrombi everywhere. The classic pentad: thrombocytopenia, microangiopathic hemolytic anemia (schistocytes), fever, neurologic changes, and renal dysfunction. Treatment is plasma exchange (plasmapheresis). Do NOT give platelets — it fuels more clotting.
HIT — heparin-induced thrombocytopenia
An immune reaction to heparin (typically 5–10 days in) that paradoxically causes clotting, not bleeding. Stop all heparin (including flushes), and switch to a non-heparin anticoagulant (argatroban, bivalirudin, fondaparinux). Do NOT give platelets, and do not start warfarin alone.
DIC and drug/marrow causes
DIC consumes platelets alongside clotting factors. Many drugs and chemotherapy suppress production. The cause shapes whether you treat with product replacement, immunosuppression, plasma exchange, or stopping the offending agent.
Assessment Findings
For destructive/productive causes, look for mucocutaneous bleeding: petechiae, purpura, ecchymoses, gum and nose bleeds, heavy menses, and prolonged oozing. Bleeding risk tracks the count — spontaneous bleeding becomes a serious threat below ~20,000/µL, and intracranial hemorrhage is the feared complication. For the clotting disorders (TTP, HIT), watch instead for new thromboses — neurologic changes and renal dysfunction in TTP, or new DVT/PE/limb ischemia in HIT. A platelet drop of > 50% in a patient on heparin should prompt HIT workup.
Nursing Priorities
Implement bleeding precautions
No IM injections, soft toothbrush and electric razor, avoid rectal temps/suppositories, hold pressure after sticks, fall prevention, and stool softeners to prevent straining. Assess for occult and overt bleeding every shift.
Know when NOT to transfuse platelets
In TTP and HIT, platelet transfusion is generally contraindicated (it can worsen thrombosis) — reserved for life-threatening bleeding only. In ITP it’s reserved for serious bleeding because transfused platelets are destroyed. Know the cause before assuming “low platelets = give platelets.”
For HIT: stop heparin completely
Remove all sources of heparin — IV, subcutaneous prophylaxis, line flushes, and heparin-coated catheters. Anticipate an alternative anticoagulant; flag the chart and band the patient for heparin allergy/HIT.
Monitor counts and response
Trend the platelet count and bleeding/clotting signs, and evaluate response to the specific therapy (steroids/IVIG, plasma exchange, anticoagulant switch).
Therapeutic Communication Considerations
Patients are often alarmed by sudden bruising and bleeding or by being told a routine drug (heparin) caused a serious reaction. Explain the specific cause and why the treatment fits it — including the counterintuitive points that they may NOT receive platelets, or that heparin must be avoided for life after HIT. Reassure them that bleeding precautions are temporary safety measures, and address anxiety about activity restrictions and the visible signs of their condition.
Patient & Family Education
Teach home bleeding precautions (soft toothbrush, electric razor, avoid NSAIDs/aspirin, no contact sports), how to apply pressure, and the bleeding signs that mean seek care (especially severe headache or neuro changes = possible intracranial bleed). After HIT, teach lifelong heparin avoidance — carry a medical alert and tell every future provider. For ITP, review steroid side effects and infection precautions; for TTP, the need for ongoing follow-up given relapse risk.
NCLEX Pearls
- ✦Thrombocytopenia = platelets <150,000; spontaneous bleeding risk climbs below ~20,000/µL.
- ✦TTP and HIT are CLOTTING disorders — do NOT give platelets (it worsens thrombosis).
- ✦TTP pentad: thrombocytopenia, hemolytic anemia (schistocytes), fever, neuro changes, renal dysfunction → plasma exchange.
- ✦HIT: platelet drop (often >50%) ~5–10 days after heparin → STOP all heparin, switch to argatroban/bivalirudin.
- ✦ITP = immune destruction → steroids/IVIG; transfused platelets are also destroyed.
- ✦Always identify the cause — 'low platelets' does not automatically mean 'transfuse platelets.'
Related Resources
Standards & sources
Fact-checked Jun 21, 2026This page is written to align with AABB (transfusion standards) · American Society of Hematology (ASH). It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →